Copyright Reports & Markets. All rights reserved.

Global Decentralized Clinical Trials (DCTs) Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Interventional
    • 1.2.3 Observational
    • 1.2.4 Expanded Access
  • 1.3 Market by Application
    • 1.3.1 Global Decentralized Clinical Trials (DCTs) Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Oncology
    • 1.3.3 Cardiovascular
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Decentralized Clinical Trials (DCTs) Market Perspective (2016-2027)
  • 2.2 Decentralized Clinical Trials (DCTs) Growth Trends by Regions
    • 2.2.1 Decentralized Clinical Trials (DCTs) Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Decentralized Clinical Trials (DCTs) Historic Market Share by Regions (2016-2021)
    • 2.2.3 Decentralized Clinical Trials (DCTs) Forecasted Market Size by Regions (2022-2027)
  • 2.3 Decentralized Clinical Trials (DCTs) Industry Dynamic
    • 2.3.1 Decentralized Clinical Trials (DCTs) Market Trends
    • 2.3.2 Decentralized Clinical Trials (DCTs) Market Drivers
    • 2.3.3 Decentralized Clinical Trials (DCTs) Market Challenges
    • 2.3.4 Decentralized Clinical Trials (DCTs) Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue
    • 3.1.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue (2016-2021)
    • 3.1.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Players (2016-2021)
  • 3.2 Global Decentralized Clinical Trials (DCTs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Decentralized Clinical Trials (DCTs) Revenue
  • 3.4 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio
    • 3.4.1 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Decentralized Clinical Trials (DCTs) Revenue in 2020
  • 3.5 Decentralized Clinical Trials (DCTs) Key Players Head office and Area Served
  • 3.6 Key Players Decentralized Clinical Trials (DCTs) Product Solution and Service
  • 3.7 Date of Enter into Decentralized Clinical Trials (DCTs) Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Decentralized Clinical Trials (DCTs) Breakdown Data by Type

  • 4.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Type (2016-2021)
  • 4.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2022-2027)

5 Decentralized Clinical Trials (DCTs) Breakdown Data by Application

  • 5.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Application (2016-2021)
  • 5.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Decentralized Clinical Trials (DCTs) Market Size (2016-2027)
  • 6.2 North America Decentralized Clinical Trials (DCTs) Market Size by Type
    • 6.2.1 North America Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2021)
    • 6.2.2 North America Decentralized Clinical Trials (DCTs) Market Size by Type (2022-2027)
    • 6.2.3 North America Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2027)
  • 6.3 North America Decentralized Clinical Trials (DCTs) Market Size by Application
    • 6.3.1 North America Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2021)
    • 6.3.2 North America Decentralized Clinical Trials (DCTs) Market Size by Application (2022-2027)
    • 6.3.3 North America Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2027)
  • 6.4 North America Decentralized Clinical Trials (DCTs) Market Size by Country
    • 6.4.1 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2016-2021)
    • 6.4.2 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Decentralized Clinical Trials (DCTs) Market Size (2016-2027)
  • 7.2 Europe Decentralized Clinical Trials (DCTs) Market Size by Type
    • 7.2.1 Europe Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2021)
    • 7.2.2 Europe Decentralized Clinical Trials (DCTs) Market Size by Type (2022-2027)
    • 7.2.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2027)
  • 7.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Application
    • 7.3.1 Europe Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2021)
    • 7.3.2 Europe Decentralized Clinical Trials (DCTs) Market Size by Application (2022-2027)
    • 7.3.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2027)
  • 7.4 Europe Decentralized Clinical Trials (DCTs) Market Size by Country
    • 7.4.1 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2016-2021)
    • 7.4.2 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size (2016-2027)
  • 8.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Type
    • 8.2.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Application
    • 8.3.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region
    • 8.4.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Decentralized Clinical Trials (DCTs) Market Size (2016-2027)
  • 9.2 Latin America Decentralized Clinical Trials (DCTs) Market Size by Type
    • 9.2.1 Latin America Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2021)
    • 9.2.2 Latin America Decentralized Clinical Trials (DCTs) Market Size by Type (2022-2027)
    • 9.2.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2027)
  • 9.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Application
    • 9.3.1 Latin America Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2021)
    • 9.3.2 Latin America Decentralized Clinical Trials (DCTs) Market Size by Application (2022-2027)
    • 9.3.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2027)
  • 9.4 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country
    • 9.4.1 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2016-2021)
    • 9.4.2 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size (2016-2027)
  • 10.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Type
    • 10.2.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Application
    • 10.3.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country
    • 10.4.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Medidata
    • 11.1.1 Medidata Company Details
    • 11.1.2 Medidata Business Overview
    • 11.1.3 Medidata Decentralized Clinical Trials (DCTs) Introduction
    • 11.1.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
    • 11.1.5 Medidata Recent Development
  • 11.2 IQVIA
    • 11.2.1 IQVIA Company Details
    • 11.2.2 IQVIA Business Overview
    • 11.2.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction
    • 11.2.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
    • 11.2.5 IQVIA Recent Development
  • 11.3 Labcorp
    • 11.3.1 Labcorp Company Details
    • 11.3.2 Labcorp Business Overview
    • 11.3.3 Labcorp Decentralized Clinical Trials (DCTs) Introduction
    • 11.3.4 Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
    • 11.3.5 Labcorp Recent Development
  • 11.4 PRA Health Sciences
    • 11.4.1 PRA Health Sciences Company Details
    • 11.4.2 PRA Health Sciences Business Overview
    • 11.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction
    • 11.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
    • 11.4.5 PRA Health Sciences Recent Development
  • 11.5 Parexel
    • 11.5.1 Parexel Company Details
    • 11.5.2 Parexel Business Overview
    • 11.5.3 Parexel Decentralized Clinical Trials (DCTs) Introduction
    • 11.5.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
    • 11.5.5 Parexel Recent Development
  • 11.6 ICON
    • 11.6.1 ICON Company Details
    • 11.6.2 ICON Business Overview
    • 11.6.3 ICON Decentralized Clinical Trials (DCTs) Introduction
    • 11.6.4 ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
    • 11.6.5 ICON Recent Development
  • 11.7 Oracle
    • 11.7.1 Oracle Company Details
    • 11.7.2 Oracle Business Overview
    • 11.7.3 Oracle Decentralized Clinical Trials (DCTs) Introduction
    • 11.7.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
    • 11.7.5 Oracle Recent Development
  • 11.8 CRF Health
    • 11.8.1 CRF Health Company Details
    • 11.8.2 CRF Health Business Overview
    • 11.8.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction
    • 11.8.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
    • 11.8.5 CRF Health Recent Development
  • 11.9 Clinical Ink
    • 11.9.1 Clinical Ink Company Details
    • 11.9.2 Clinical Ink Business Overview
    • 11.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction
    • 11.9.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
    • 11.9.5 Clinical Ink Recent Development
  • 11.10 Medable
    • 11.10.1 Medable Company Details
    • 11.10.2 Medable Business Overview
    • 11.10.3 Medable Decentralized Clinical Trials (DCTs) Introduction
    • 11.10.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
    • 11.10.5 Medable Recent Development
  • 11.11 Science 37
    • 11.11.1 Science 37 Company Details
    • 11.11.2 Science 37 Business Overview
    • 11.11.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction
    • 11.11.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
    • 11.11.5 Science 37 Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Decentralized Clinical Trials (DCTs) Scope and Market Size
    Decentralized Clinical Trials (DCTs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Decentralized Clinical Trials (DCTs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Interventional
    Observational
    Expanded Access

    Segment by Application
    Oncology
    Cardiovascular
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Medidata
    IQVIA
    Labcorp
    PRA Health Sciences
    Parexel
    ICON
    Oracle
    CRF Health
    Clinical Ink
    Medable
    Science 37

    Buy now